GRACE HUGHES: Open Payments
NPI 1497128029 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,275 in 57 payments from 14 companies in 2025. Trend: 2023 $1,108 · 2024 $996 · 2025 $1,275
Food & beverage: $1,275
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $293 |
| SANOFI-AVENTIS U.S. LLC | 10 | $226 |
| ARS Pharmaceuticals Operations, Inc. | 13 | $186 |
| Regeneron Healthcare Solutions, Inc. | 6 | $146 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Genentech USA, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Organon LLC | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
Products named: DUPIXENT, NEFFY, FASENRA, Rhapsido, Xolair, TEZSPIRE, TRELEGY ELLIPTA, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
